[HTML][HTML] The opioid system in depression

LA Jelen, JM Stone, AH Young, MA Mehta - Neuroscience & Biobehavioral …, 2022 - Elsevier
Opioid receptors are widely distributed throughout the brain and play an essential role in
modulating aspects of human mood, reward, and well-being. Accumulating evidence …

[HTML][HTML] Evidence on buprenorphine dose limits: a review

LA Grande, D Cundiff, MK Greenwald… - Journal of addiction …, 2023 - journals.lww.com
Objectives As overdose deaths from fentanyl continue to increase, optimizing use of
medications for opioid use disorder has become increasingly important. Buprenorphine is a …

Patient-reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: a randomized clinical …

N Lintzeris, AJ Dunlop, PS Haber, DI Lubman… - JAMA Network …, 2021 - jamanetwork.com
Importance Patient-reported outcomes in the treatment of opioid dependence may differ
between subcutaneously administered depot buprenorphine and daily sublingual …

Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19

CS Davis, EA Samuels - International Journal of Drug Policy, 2021 - Elsevier
In response to the concurrent opioid overdose and COVID-19 epidemics, the United States
(US) Drug Enforcement Administration (DEA) and other federal agencies have taken steps …

Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?

RG Carlson, R Daniulaityte, SM Silverstein… - International Journal of …, 2020 - Elsevier
Background Unintentional drug overdoses have reached epidemic levels in the US This
study tests the hypothesis that people who have used non-prescribed buprenorphine more …

Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms

PC Treitler, CF Bowden, J Lloyd, M Enich… - Journal of substance …, 2022 - Elsevier
Objective The COVID-19 pandemic led to unprecedented temporary federal and state
regulatory flexibilities that rapidly transformed medication for opioid use disorder (MOUD) …

Trends and characteristics of buprenorphine-involved overdose deaths prior to and during the COVID-19 pandemic

LJ Tanz, CM Jones, NL Davis, WM Compton… - JAMA Network …, 2023 - jamanetwork.com
Importance Buprenorphine remains underused in treating opioid use disorder, despite its
effectiveness. During the onset of the COVID-19 pandemic, the US government …

When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use

KE Smith, JM Rogers, JC Strickland… - The American journal of …, 2021 - Taylor & Francis
Background: Originally believed to be an atypical antidepressant acting at serotonin
transporters, tianeptine is now known to also be an atypical agonist at mu-opioid receptors …

Current and future therapeutic options in pain management: Multi-mechanistic opioids involving both MOR and NOP receptor activation

F Coluzzi, L Rullo, MS Scerpa, LM Losapio, M Rocco… - CNS drugs, 2022 - Springer
Opioids are widely used in chronic pain management, despite major concerns about their
risk of adverse events, particularly abuse, misuse, and respiratory depression from …

Medications for opioid use disorders: clinical and pharmacological considerations

ND Volkow, C Blanco - The Journal of clinical investigation, 2020 - Am Soc Clin Investig
The opioid epidemic, now in its second decade, is one of the most challenging public health
crises in the US. Providing an effective response is complicated by multiple underlying …